Investigators have created computer-generated models to bridge the gap between 'test tube' data about neurons and the function of those cells in the living brain. Their study could help in the ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a Phase 3, clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a ...